Back to Results

Elekta AB ADR (EKTAY)

Elekta AB ADR is a depositary receipt representing common stock of Elekta AB (publ), a Swedish medical technology company listed on OTC Markets. Through its underlying issuer, Elekta develops clinical solutions for cancer and brain disorder treatment across the Americas, Europe, the Middle East, Africa, and Asia Pacific. Its portfolio includes systems and software for radiation therapy, stereotactic radiosurgery, brachytherapy, neurosurgery, treatment planning, and oncology workflow management, along with related quality assurance, motion management, training, support, and maintenance services. Founded in 1972 and headquartered in Stockholm, Sweden, Elekta also serves veterinary radiation therapy applications through its broader medical technology platform.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Payment Date Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-EKTA.Y
$6.08
16.0% Upside
Fair
Not available
Not available
Good
September 30, 2026
2.9%
November 25, 2026
2.7x
1.3x
2.113 B
2.663 B
24.8%
82.1%
3.5
-255.2%
-672.7%
Valuation • Fair Value

Elekta AB ADR (OTC-EKTA.Y) Fair Value by Valuation Model

Review the available estimates for Elekta AB ADR (OTC-EKTA.Y), including DCF Fair Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$6.08

Estimated upside of 16.0% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$8.67

Discounted cash flow valuation reference.

DDM Fair Value

$2.58

Dividend discount model valuation reference.

EPV Fair Value

$5

Earnings power value estimate.

Comps Fair Value

$5.97

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 6 available valuation references for Elekta AB ADR (OTC-EKTA.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Elekta AB ADR (OTC-EKTA.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.744 B

Current operating scale indicator.

Revenue Forecast

1.757 B

Forward revenue estimate.

EBITDA

193.7 M

Current operating profitability reference.

EBITDA Forecast

354.2 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Elekta AB ADR (OTC-EKTA.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Elekta AB ADR (OTC-EKTA.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-3.17

No elevated caution signal from this screen.

Altman Z-Score

3.5

Relatively strong balance-sheet zone.

FCF / Net Income

-672.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Elekta AB ADR (OTC-EKTA.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Elekta AB ADR (OTC-EKTA.Y)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 25, 2026

Days to Earnings

64

Dividend Payment Date

September 30, 2026

Dividend Yield

2.9%

Current income yield reference.

Payout Ratio

-255.2%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Elekta AB ADR (OTC-EKTA.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Elekta AB ADR (OTC-EKTA.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for Elekta AB ADR (OTC-EKTA.Y) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Elekta AB ADR (OTC-EKTA.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Elekta AB ADR (OTC-EKTA.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Elekta AB ADR (OTC-EKTA.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Elekta AB ADR (OTC-EKTA.Y) Stock FAQ

Data-supported answers about Elekta AB ADR (OTC-EKTA.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$6.08
Estimated upside 16.0%
Valuation Rating
Undervalued
Estimated upside of 16.0%
Financial Health
Good
Current financial-health read

The current fair value estimate for Elekta AB ADR (OTC-EKTA.Y) is $6.08. This implies an estimated upside of 16.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 16.0% versus the current market price.

The current financial health read for Elekta AB ADR (OTC-EKTA.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Elekta AB ADR (OTC-EKTA.Y) is November 25, 2026.

Based on the current data, dividend yield is 2.9%, payment date is September 30, 2026.

The current market capitalization listed for Elekta AB ADR is 2.113 B.

The current enterprise value listed for Elekta AB ADR is 2.663 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Elekta AB ADR is OTC-EKTA.Y, and the stock is listed on OTC Markets.

Elekta AB ADR (OTC-EKTA.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Elekta AB ADR is 24.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Elekta AB ADR is 82.1%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 179.4 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 142 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 116.1 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 105.5 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 65.099 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 51.173 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 49.847 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 44.185 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 41.084 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 33.785 B
RMD NYSE ResMed Inc Fair Value Undervalued Market Cap 31.756 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 31.674 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 29.933 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Undervalued Market Cap 24.452 B
STE NYSE STERIS plc Fair Value Undervalued Market Cap 20.357 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Undervalued Market Cap 17.926 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 15.107 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.581 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 12.242 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 11.566 B